Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
US5284876A · kind A · utility
43Cited by
8References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 1992 |
| Grant date | Feb 8, 1994 |
| Priority date | — |
| Expiry date | Jun 11, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to a method for treating a subject for Tardive Dyskinesia by administering a dopaminergic agent to the subject such that the dopaminergic agent enters the brain or by administering a prodrug of a therapeutic agent. The dopaminergic agent preferably is 2 prodrug formed by coupling dopamine to a fatty acid. This invention further pertains to methods of providing pharmaceutical preparations and packaged pharmaceuticals for Tardive Dyskinesia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.